Outcomes of patients with diabetes versus patients without diabetes hospitalized with acute heart failure
Wan SH, Slusser JP, Hodge DO, Chen HH
Am J Cardiol. 2022;165:65-71
Leggi
Predictors of cardio-kidney complications and treatment failure in patients with chronic kidney disease and type 2 diabetes treated with SGLT2 inhibitors
Kovesdy C , Schmedt N, Folkerts K, et al.
BMC Med. 2022;20(1):2
Leggi
Comprehensive management of cardiovascular risk factors for adults with type 2 diabetes: a scientific statement from the American Heart Association
Joseph JJ, Deedwania P, Acharya T, et al.
Circulation. 2022;CIR0000000000001040
Leggi
Genetic risk score enhances coronary artery disease risk prediction in individuals with type 1
Lithovius R, Antikainen AA, Mutter S, et al.
Diabetes Care. 2022;dc210974
Leggi
Trends in all-cause mortality among people with diagnosed diabetes in high-income settings: a multicountry analysis of aggregate data
Magliano DJ, Chen L, Carstensen B, et al.
Lancet Diabetes Endocrinol. 2022;S2213-8587(21):00327-2
Leggi
Effect of dapagliflozin on hematocrit in patients with type 2 diabetes at high cardiovascular risk: observations from DECLARE-TIMI 58
Kolkailah AA, Wiviott SD, Raz I, et al.
Diabetes Care. 2022;dc211668
Leggi
Changes in the prevalence of symptoms of depression, loneliness, and insomnia in U.S. older adults with type 2 diabetes during the COVID-19 pandemic: the Look AHEAD study
Chao AM, Wadden TA, Clark JM, et al.
Diabetes Care. 2022;45(1):74-82.
Leggi
Does COVID-19 predispose patients to type 1 diabetes mellitus?
Ata A, Jalilova A, Kırkgöz T, et al.
Clin Pediatr Endocrinol. 2022;31(1):33-37.
Leggi
Continuous glucose monitoring in the hospital: an update in the era of COVID-19
Gothong C, Singh LG, Satyarengga M, Spanakis EK.
Curr Opin Endocrinol Diabetes Obes. 2022;29(1):1-9.
Leggi
The type 2 diabetes ‘modern preventable pandemic’ and replicable lessons from the COVID-19 crisis
Singer ME, Dorrance KA, Oxenreiter MM, et al.
Prev Med Rep. 2022;25:101636
Leggi